Novakova I - Search Results

1

Low-titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half-life after immune tolerance induction.

Dardikh M, Albert T, Masereeuw R, Oldenburg J, Novakova I, van Heerde WL, Verbruggen B. Dardikh M, et al. Among authors: novakova i. J Thromb Haemost. 2012 Apr;10(4):706-8. doi: 10.1111/j.1538-7836.2012.04645.x. J Thromb Haemost. 2012. PMID: 22284849 Free article. No abstract available.

2

A 4% solution of bovine serum albumin may be used in place of factor VIII:C deficient plasma in the control sample in the Nijmegen Modification of the Bethesda factor VIII:C inhibitor assay.

Verbruggen B, van Heerde W, Novákovà I, Lillicrap D, Giles A. Verbruggen B, et al. Among authors: novakova i. Thromb Haemost. 2002 Aug;88(2):362-4. Thromb Haemost. 2002. PMID: 12195715 No abstract available.

3

The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.

Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. Verbruggen B, et al. Among authors: novakova i. Thromb Haemost. 1995 Feb;73(2):247-51. Thromb Haemost. 1995. PMID: 7792738

4

The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.

Verbruggen B, Giles A, Samis J, Verbeek K, Mensink E, Novákovà I. Verbruggen B, et al. Among authors: novakova i. Thromb Haemost. 2001 Dec;86(6):1435-9. Thromb Haemost. 2001. PMID: 11776311

5

Diagnosis of factor VIII deficiency.

Verbruggen B, Meijer P, Novákova I, Van Heerde W. Verbruggen B, et al. Among authors: novakova i. Haemophilia. 2008 Jul;14 Suppl 3:76-82. doi: 10.1111/j.1365-2516.2008.01715.x. Haemophilia. 2008. PMID: 18510526 Review.

6

Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population.

Boekhorst J, Verbruggen B, Lavergne JM, Costa JM, Schoormans SC, Brons PP, van Kraaij MG, Nováková IR, van Heerde WL. Boekhorst J, et al. Br J Haematol. 2005 Oct;131(1):109-17. doi: 10.1111/j.1365-2141.2005.05737.x. Br J Haematol. 2005. PMID: 16173970 Free article.

7

Use of the platelet function analyzer to minimize bleeding complications after renal biopsy.

van den Hoogen MW, Verbruggen BW, Polenewen R, Hilbrands LB, Nováková IR. van den Hoogen MW, et al. Thromb Res. 2009;123(3):515-22. doi: 10.1016/j.thromres.2008.07.001. Epub 2008 Aug 13. Thromb Res. 2009. PMID: 18703219

8

Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.

Boekhorst J, Lari GR, D'Oiron R, Costa JM, Nováková IR, Ala FA, Lavergne JM, VAN Heerde WL. Boekhorst J, et al. Among authors: novakova ir. Haemophilia. 2008 Jul;14(4):729-35. doi: 10.1111/j.1365-2516.2008.01694.x. Epub 2008 May 12. Haemophilia. 2008. PMID: 18503540

9

Prophylactic effect of recombinant factor VIIa in factor VII deficient patients.

Mathijssen NC, Masereeuw R, Verbeek K, Lavergne JM, Costa JM, van Heerde WL, Nováková IR. Mathijssen NC, et al. Br J Haematol. 2004 May;125(4):494-9. doi: 10.1111/j.1365-2141.2004.04942.x. Br J Haematol. 2004. PMID: 15142120 Free article.

10

Factor VIIA determination compared to D-Dimer in diagnosis of deep venous thrombosis.

Janssen MC, Verbruggen BW, ter Hark PJ, Nováková IR. Janssen MC, et al. Among authors: novakova ir. Thromb Res. 1997 Jun 1;86(5):423-6. doi: 10.1016/s0049-3848(97)00088-1. Thromb Res. 1997. PMID: 9211634 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters